A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa
Recruiting
- Conditions
- Hidradenitis Suppurativa
- Registration Number
- jRCT2051240088
- Lead Sponsor
- Incyte Biosciences Japan G.K.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 16
Inclusion Criteria
- Completion of the study treatment period of the originating parent study (INCB 54707-301 or INCB 54707-302).
- Agreement to use contraception.
- Willing and able to comply with the study protocol and procedures.
- Further inclusion criteria apply.
Exclusion Criteria
- Participation in the extension study could expose the participant to an undue safety risk.
- Women who are pregnant (or who are considering pregnancy) or breastfeeding.
- Further exclusion criteria apply.
Study & Design
- Study Type
- Interventional
- Study Design
- parallel assignment
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method